Sage Journals: Discover world-class research

Open access

Research article

First published 2024-5

Higher Derived Time in Range With IDegLira Versus Insulin Glargine U100 in People With Type 2 Diabetes

Athena Philis-Tsimikas, Vanita R. Aroda, Christophe De Block [...]

Journal of Diabetes Science and Technology

Open access

Research article

First published 2022-09

Continuous Glucose Monitoring-Recorded Hypoglycemia with Insulin Degludec or Insulin Glargine U100 in People with Type 1 Diabetes Prone to Nocturnal Severe Hypoglycemia

Julie Maria Bøggild Brøsen, Rikke Mette Agesen, Amra Ciric Alibegovic [...]

Diabetes Technology & Therapeutics

Retricted access

Research article

First published 2019-3

Developing,Planning and Conducting an Interim Analysis: Lessons From the DEVOTE Cardiovascular Outcomes Trial (Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Patients With Type 2 Diabetes at High Risk of Cardiovascular Events)

Hanne Theilgaard, Inger Mollerup, Ida Carøe Helmark [...]

Therapeutic Innovation & Regulatory Science

Free access

Research article

First published 2025-3

The Effect of Insulin Degludec Versus Insulin Glargine U100 on Glucose Metrics Recorded During Continuous Glucose Monitoring in People With Type 1 Diabetes and Recurrent Nocturnal Severe Hypoglycemia

Julie Maria Bøggild Brøsen, Rikke Mette Agesen, Amra Ciric Alibegovic [...]

Journal of Diabetes Science and Technology

Retricted access

Brief report

First published 2020-01

Greater Suppression of Glucagon,Lipolysis,and Ketogenesis with Insulin Glargine U300 as Compared with Glargine U100 in Type 1 Diabetes Mellitus

Paola Lucidi, Francesca Porcellati, Patrizia Cioli [...]

Diabetes Technology & Therapeutics

Retricted access

Research article

First published 2017-08

The Durability of Basal Insulin Affects Day-to-Day Glycemic Variability Assessed by Continuous Glucose Monitoring in Type 2 Diabetes Patients: A Randomized Crossover Trial

Hiroyuki Iuchi, Masaya Sakamoto, Daisuke Matsutani [...]

Diabetes Technology & Therapeutics

Retricted access

Case report

First published 2016-10

Insulin Allergy

Kayla M. Natali, Jennifer D. Goldman

Journal of Pharmacy Technology

Open access

Research article

First published 2020-11

Risk factors for kidney disorders in patients with type 2 diabetes at high cardiovascular risk: An exploratory analysis (DEVOTE 12)

Aslam Amod, John B Buse, Darren K McGuire [...]

Diabetes & Vascular Disease Research

Retricted access

Research article

First published 2023-03

Comparison of Insulin Glargine 300 U/mL and Insulin Degludec 100 U/mL Around Spontaneous Exercise Sessions in Adults with Type 1 Diabetes: A Randomized Cross-Over Trial (ULTRAFLEXI-1 Study)

Othmar Moser, Alexander Müller, Felix Aberer [...]

Diabetes Technology & Therapeutics

Free access

Research article

First published 2018-3

Day-to-Day and Within-Day Variability in Glucose-Lowering Effect Between Insulin Degludec and Insulin Glargine (100 U/mL and 300 U/mL): A Comparison Across Studies

Tim Heise, Kadriye Kaplan, Hanne L. Haahr

Journal of Diabetes Science and Technology

Search results